QIMR Bergdorfer Medical Research Institute
QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International
Under the agreement, Proteomics International has the right to use the markers to develop and commercialize a blood-based early detection test for esophageal cancer.
Acne GWAS Uncovers New Risk Loci, Overlap With Other Conditions
A genome-wide association study involving more than 20,000 acne cases and almost 600,000 controls led to new risk loci and a polygenic risk score.
Pale Melanoma Susceptibility Linked to Albinism-Related Genes
With array and exome data, Australian investigators saw apparent ties between amelanotic/hypomelanotic melanoma and rare albinism gene changes.
GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx in Australia
A pilot study enrolling up to 15 patients will validate CapeDx's utility to match patients to approved drugs and clinical trials based on whole-genome and tumor sequencing.
Cutaneous Melanoma Clues Found From Risky SNPs, Related Traits Analyses
Researchers used case and control genotypes alongside related trait, transcriptome, and population data to identify 85 cutaneous melanoma candidate loci.